Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal MEDICINUS Jurnal Agromedicine Unila: Jurnal Kesehatan dan Agromedicine
Andika Yusuf Ramadhan
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Dentistry Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Nursing Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : MEDICINUS

 1 
The Multifaceted Nature of Clopidogrel Resistance: Integrating Pharmacodynamic, Pharmacokinetic, and Pharmacogenomic  Andika Yusuf Ramadhan
MEDICINUS Vol. 38 No. 9 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/pex51w69

Abstract

Clopidogrel is a second-generation thienopyridine drug that acts as a platelet aggregation agent and widely used to treat cardiovascular disease by preventing the formation of thrombus.  Growing studies in the cardiovascular field have led to a new term, which is clopidogrel resistance. The mechanism of clopidogrel resistance could be the consequence of several factors such as decreased bioavailability due to pharmacokinetic changes, PK/PD interactions with other drugs, and genetic polymorphisms. Genetic polymorphisms affect the metabolism of clopidogrel prodrug, leading to sub-therapeutic concentrations of active metabolites. In addition, mutations in the P2Y12 receptor gene also impact platelet activity against agonis and antagonist ADP.  Measurement of platelet activity and pharmacogenomics profiling could help in diagnosing and monitoring clopidogrel therapy with suspicion of clopidogrel resistance.
Co-Authors Diana Mayasari Khairunissa Berawi